CLASS II Device recall · Reported 11 Mar 2026 · FDA Enforcement Report

Endocavity ultrasonic probe recalled by Esaote S.p.a

Esaote is recalling Endocavity ultrasonic probe, distributed nationwide in the US. The recall was initiated on 14 Mar 2025 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI 0805604453891, Serial Numbers: 241700533C, 241700529C, 241700607C, 241700536C, 241700613C.
Quantity recalled5 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1490-2026
FDA event ID
98339
Recalling firm
Esaote, Sesto Fiorentino, N/A
Classification
Class II
Status
Completed
Recall initiated
14 Mar 2025
FDA classified
3 Mar 2026
Reported
11 Mar 2026
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Packaging Defects

Timeline

14 Mar 2025Recall initiated by company
3 Mar 2026Classified by FDA+354 days
11 Mar 2026Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

A potential weakness has been identified in the probe body, so that, in a specific production batch, liquid may leak from the terminal part of the casing near the cable.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

Esaote Endocavity ultrasonic probe, Model E 3-12, REF 120000038

Where it was distributed

US: Nationwide distribution in the states of NC and TX.

Nationwide North CarolinaTexas

Questions about this recall

Why was it recalled?

A potential weakness has been identified in the probe body, so that, in a specific production batch, liquid may leak from the terminal part of the casing near the cable.

Which lots are affected?

UDI 0805604453891, Serial Numbers: 241700533C, 241700529C, 241700607C, 241700536C, 241700613C.

Where was it sold?

US: Nationwide distribution in the states of NC and TX.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Esaote

All 9
ReportedClassRecallCompanyReasonWhere
DeviceCLASS IIAC/DC Power Supply recalled by Esaote S.p.aEsaoteOtherNationwide
DeviceCLASS IIAC/DC Power Supply recalled by Esaote S.p.aEsaoteOtherNationwide
DeviceCLASS IIMyLab Seven recalled by Esaote S.p.aEsaoteDevice MalfunctionNationwide
DeviceCLASS IIMyLab Alpha recalled by Esaote S.p.aEsaoteDevice MalfunctionNationwide
DeviceCLASS IIMyLab Gamma recalled by Esaote S.p.aEsaoteDevice MalfunctionNationwide

Other Other Medical Devices recalls

All 13,986